Latest News
Morgan Stanley Boosts CrowdStrike Rating on Strong Growth Outlook
Morgan Stanley upgraded CrowdStrike to overweight, raising its price target to $510, as the cybersecurity firm projected fiscal 2027 revenue above Wall Street estimates.
AbbVie's Early Obesity Drug Trial Shows Promising Weight Loss Results
AbbVie reported its amylin-based obesity candidate ABBV-295 led to significant weight reduction in an early study, with no serious safety issues observed. The data marks a strategic step for the company as it seeks growth beyond immunology.
United Airlines Warns of Q1 Profit Hit as Jet Fuel Costs Soar
United Airlines Holdings stock declined after the carrier warned rising jet fuel expenses will significantly impact first-quarter results, with TD Cowen projecting adjusted EPS could drop to as low as $0.05.
Crude Plunges 15% as Trump Hints at Iran Conflict Resolution
Oil prices collapsed nearly 15% Tuesday after Donald Trump indicated the Iran conflict might conclude shortly, erasing Monday's panic-driven surge above $119. G7 ministers deferred tapping emergency reserves.
Intuit Shares Slide on Spending Concerns Despite Analyst Upgrade
Intuit shares dropped nearly 4% Tuesday as investors focused on elevated spending forecasts overshadowing a bullish analyst upgrade and strong January-quarter results.
BlackRock Sees Inflation Risk from Middle East Energy Shock, Favors Stocks
BlackRock cautions that energy supply disruptions from Middle East tensions may sustain inflationary pressures, though it views the shock as likely lasting weeks rather than months. The firm remains underweight long-term U.S. bonds and prefers U.S. and Japanese stocks.
J&J Seeks Earlier Use of Tecvayli in Europe Following US Myeloma Approval
Johnson & Johnson has submitted an application to European regulators to expand the use of its myeloma drug Tecvayli as a monotherapy after just one prior treatment. This follows recent U.S. approval for a Tecvayli combination and is supported by trial data showing a 71% reduction in disease progression risk.
Oil Plummets 13% as Trump Hints at Iran Conflict Resolution
Oil prices crashed over 13% Tuesday after U.S. President Donald Trump indicated the Iran conflict might conclude shortly, erasing the prior day's surge driven by supply fears. Brent crude fell $12.46 to $86.50 per barrel.
Bitcoin Surges Past $70K Amid Easing Geopolitical Tensions, ETF Inflows
Bitcoin reclaimed the $70,000 level, rising 3.3% as geopolitical tensions eased and crude oil prices tumbled. The rally was supported by renewed inflows into spot Bitcoin ETFs and significant corporate buying.
P&G's Gillette Commits $1 Billion to New Boston HQ Amid Growth Challenges
Procter & Gamble's Gillette brand is investing close to $1 billion to establish a new global headquarters and research hub in South Boston, maintaining its commercial and R&D presence in the city while shifting manufacturing to Andover in 2026.
Gold Surges Past $5,220 as Oil Plunge Eases Inflation Pressure
Gold rebounded sharply Tuesday, climbing above $5,220 an ounce as a steep drop in crude oil prices and a softer dollar alleviated near-term inflation concerns ahead of key U.S. economic data.
Teradyne Files German Copyright Suit Against Chinese Robotics Firm Elite Robots
Teradyne Robotics has initiated a copyright lawsuit in Germany against the German subsidiary of China's Elite Robots, claiming unauthorized use of Universal Robots software. The company also notified European safety authorities about potential issues with Elite Robots' machines.